Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. - Wikidata - awgldk - TriplyDB

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

http://www.wikidata.org/entity/Q33181094

about

Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.An analysis of why highly similar enzymes evolve differently Rapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysis.Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico.Limited spread of penicillin-nonsusceptible pneumococci, Skåne County, Sweden Population structure, epidemiology and antibiotic resistance patterns of Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine introduction in Eastern Gambia Community prescribing and resistant Streptococcus pneumoniae.Antibiotic use in Hispanic households, New York city.Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location.Availability of antibiotics without prescription in New York City.Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States Etiology issues and problems of antibiotic resistance.Antimicrobial peptides: their physicochemical properties and therapeutic application.Predicting the emergence of antimicrobial resistance.Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria.Antibiotic selection of multiply resistant pneumococci.

P2860

Q30772203-FAFE8B41-08D2-4CF3-9F3D-DA4A8FD89C16 Q33187513-D9A8C721-C30A-4C06-B81A-5384D4AD8A2B Q34347889-D48C6E72-CF8E-440F-BC5E-023C628DA3B3 Q34616960-C06D07A3-7B0E-4771-8FBC-0765F1FF62E5 Q34946620-F8008233-CDC5-4903-9FE2-1770D6617DB7 Q35013754-EFA3E24F-A333-47CF-8002-98A6AFDC3BBA Q35022423-458AEB00-803A-477F-98D6-802735FC792E Q35880428-5F7C27D8-1D84-4C6D-82A8-D195AB8A2B02 Q35907857-84C29E8D-4B1F-45A7-9006-82B6FF0E86EF Q36009361-8EEABBE9-FA3E-4A04-8577-69777E5F25F5 Q36088225-D07BEC02-6587-4E1C-AE7F-A9830B50DC01 Q36095014-5A55E9EB-D25F-41F2-8CF2-E391E4E300C6 Q36272407-005AF387-EA50-483B-BAB4-DA9637BAE142 Q37187505-DE7EDB52-4CD6-4A5B-A40E-CEA088316A35 Q37811605-94066E67-61DA-4CAF-A4AE-52FC4AFF89D7 Q38000122-94BD8CBF-71E8-43AA-9DD7-47653F6E0CB4 Q43974796-640518FD-A671-4EF8-947B-B5AAA063AE67 Q44705813-B615AF5A-951E-40B7-BF72-2CDDDDD3EBDA Q46576587-47D7E410-47CA-44D6-886C-5B9BDBDE1604 Q54001529-9A01CC1A-337D-47F6-B630-2F199B02B287

P2860

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

http://www.wikidata.org/entity/Q33181094

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

@ast

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

@en

type

label

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

@ast

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

@en

prefLabel

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

@ast

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

@en

P1433

Q33181094-64BF7612-D675-4731-B091-D4BF7FBE5D14

P1476

Q33181094-DD2B8122-C947-43FF-9AE2-E9A555211DDC

P2093

Q33181094-08D76367-C413-439F-8ED3-BFCAF378633D

Q33181094-F36C0574-95E0-49FC-A88B-29A247E5C5AA

Q33181094-F7D0BC37-85D1-4B5B-A18C-B4A2CCC0BA58

P2860

Q33181094-122DD133-EF8B-4AB7-A7F6-A1E838E11514

Q33181094-1879DF79-8B9E-4E4C-81F1-52705CD4D94B

Q33181094-24392BC5-FDF5-4243-B031-57337C234531

Q33181094-3E0FC8C8-7A30-4360-A954-9932DDBE9B76

Q33181094-61E6F0A2-2C35-421A-B5E6-C1E1CF15970C

Q33181094-6AED3F3A-8F2D-4AB7-B0B1-E1811560C021

Q33181094-6DC38DAD-05FE-4A34-BC41-BB37A65A13E8

Q33181094-8106F348-A5A8-4791-A49C-4328AD6AA495

Q33181094-8675AAEC-388D-4962-97F5-93D9019C8D76

Q33181094-8B5B0D3B-B558-4F84-A240-CAAC073BF87F

P304

Q33181094-8FE6E562-056B-4B65-8F3F-B2561195BB35

P31

Q33181094-7618C245-5017-4C0F-8FF9-F92093461095

P356

Q33181094-0BF5BE76-A800-4CC1-B01F-19E507C57D02

P433

Q33181094-BCC952ED-8336-4551-AA99-DA3D09149782

P478

Q33181094-3AD0986C-A954-4E1E-953A-CC3C978642D8

P577

Q33181094-64E8D7F8-BC0F-4CB2-9609-760050534E3E

P5875

Q33181094-EF2577F2-8F8B-4CC2-B62B-9774B4DA053A

P698

Q33181094-2871AD9A-4066-4EC0-A746-2282C2C776FE

P921

Q33181094-F4AA4215-2597-4BE9-98BA-A0CB5329EBA8

P932

Q33181094-2BE022FD-8D1A-4EE7-A531-A58747A8AACD

P356

P1433

Emerging Infectious Diseases

P1476

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

@en

P2093

Brueggemann AB

http://www.w3.org/2001/XMLSchema#string

Diekema DJ

http://www.w3.org/2001/XMLSchema#string

Doern GV

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.

Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio.

Pneumococcal resistance patterns in Europe.

Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.

Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study.

The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals.

Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

P304

552-556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID0605.000519

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12325645

http://www.w3.org/2001/XMLSchema#string

P698

10998390

http://www.w3.org/2001/XMLSchema#string

P921

antimicrobial resistance

P932

2627961

http://www.w3.org/2001/XMLSchema#string